Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Autologous PBSC Transplant for ANLL
NCT00630565Phase 3Terminated
- Sponsor
- Masonic Cancer Center
- Start
- Jul 2006
- Primary completion
- Jul 2022
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
A Phase 3 trial of autologous hematopoietic stem cells in acute myeloid leukemia (AML), sponsored by Masonic Cancer Center. Started Jul 2006; status: terminated.
02
Drugs
autologous hematopoietic stem cells
03
Conditions
acute myeloid leukemia (AML)
Beyond the preview
Go deeper on NCT00630565.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00630565.